A Case of BRAF Mutation-positive Lung Adenocarcinoma with a Durable Response to Dabrafenib Plus Trametinib After Dose Reduction due to Organizing Pneumonia

Authors

Institutions

Publication Details

Journal
Haigan
Published
2025-04-20
DOI
https://doi.org/10.2482/haigan.65.96
Citations
1
Primary Topic
Melanoma and MAPK Pathways
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Case of BRAF Mutation-positive Lung Adenocarcinoma with a Durable Response to Dabrafenib Plus Trametinib After Dose Reduction due to Organizing Pneumonia

Tsunetaka Murayama, Natsuko Nomura, Hideo Kita, Yasukiyo Nakamura et al.
1 citations
Haigan
Melanoma and MAPK Pathways
0.81
article

A Case of BRAF Mutation-positive Lung Adenocarcinoma with a Durable Response to Dabrafenib Plus Trametinib After Dose Reduction due to Organizing Pneumonia

Tsunetaka Murayama, Natsuko Nomura, Hideo Kita, Yasukiyo Nakamura, Hiroko Fukata, Haruka Yamamoto, Yumiko Misaki, Kentaro Hizume
article en
1 citations

Abstract

No abstract available for this paper.
HaiganVol. 65(2)
Hiroshima Kyoritsu Hospital (JP), Takatsuki Red Cross Hospital (JP)
Zero hunger
Openalex Percentile: Top 29%
Melanoma and MAPK Pathways
0.81
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Case of BRAF Mutation-positive Lung Adenocarcinoma with a Durable Response to Dabrafenib Plus Trametinib After Dose Reduction due to Organizing Pneumonia — Tsunetaka Murayama, Natsuko Nomura, et al. · Haigan (2025) | TGRS Research Map | TGRS